| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2874172 | The Annals of Thoracic Surgery | 2013 | 6 Pages |
Abstract
The inclusion of nondiagnostic specimens into the conservative, worst-case-scenario calculation of NPV for EBUS-FNA in NSCLC lowers the NPV from 85.3% to 65.9%. The true NPV is likely higher than 65.9% as few nondiagnostic specimens are false negatives. Caution is imperative for the safe application of EBUS-FNA in NSCLC staging.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Bryan A. MD, PhD, Shawn S. MD, David D. MD, Eleazar P. BA, Michael A. MD, Jonathan MD, PhD, Rafael S. MD,